Clinimetric methods in Sjögren's syndrome

Seminars in Arthritis and Rheumatism

Volumn 42, Issue 6, 2013, Pages 627-639

  Hernández Molina, Gabriela ^a   Sánchez Hernández, Tania ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Activity; Clinimetry; Damage; Sicca symptoms; Sj gren's syndrome

Indexed keywords

DYE;

ARTICLE; CHALDER FATIGUE SCALE; CHRONICITY; CLINICAL EVALUATION; CLINICAL FEATURE; CORRELATION ANALYSIS; CYTOLOGY; DISEASE ACTIVITY; DISEASE COURSE; DRY EYE; DRY EYE QUESTIONNAIRE; EULAR SJOGREN SYNDROME DISEASE ACTIVITY INDEX; EXTERNAL VALIDITY; FATIGUE; FATIGUE IMPACT SCALE; FATIGUE SEVERITY SCALE; FUNCTIONAL ASSESSMENT OF CHRONIC ILLNESS THERAPY SCALE; HISTOCHEMISTRY; HUMAN; KERATOCONJUNCTIVITIS; LACRIMATION; MEDICAL ASSESSMENT; MULTIDIMENSIONAL FATIGUE INSTRUMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OCULAR SURFACE DISEASE INDEX; PRIORITY JOURNAL; PROFILE OF FATIGE AND DISCOMFORT SCALE; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; SALIVA ANALYSIS; SCHIRMER TEST; SENSITIVITY AND SPECIFICITY; SHORT FORM 36; SIALOCHEMISTRY; SIALOMETRY; SJOEGREN SYNDROME; SJOGREN SYNDROME CLINICAL ACTIVITY INDEX; SJOGREN SYNDROME DAMAGE INDEX; SJOGREN SYNDROME DISEASE ACTIVITY INDEX; SJOGREN SYNDROME DISEASE DAMAGE INDEX; SYSTEMATIC REVIEW; TEAR FLOW; VISUAL ANALOG SCALE; VITAL STAIN; XEROSTOMIA;

FATIGUE; HUMANS; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TEARS;

EID: 84881245865     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2012.09.008     Document Type: Article

References (78)

1. Ramos-Casals M., Font J. Primary Sjögren's syndrome: current and emergent aetiopathogenic concepts. Rheumatology 2005, 44:1354-1367.
2. Vitali C., Palombi G., Baldini C., Benucci M., Bombardiere S., Covelli M., et al. Sjögren's syndrome disease damage index and disease activity index. Scoring systems for the assessment of disease damage and disease activity in Sjögren's syndrome derived from an analysis of a cohort of Italian patients. Arthritis Rheum 2007, 56:2223-2231.
3. Hay E., Thomas E., Pal B., Hajeer A., Chambers H., Silman A. Weak association between subjective symptoms of and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 1998, 57:20-24.
4. Versura P., Frigato M., Mulé R., Malavolta N., Campos E. A proposal of new ocular items in Sjögren's syndrome classification criteria. Clin Exp Rheumatol 2006, 24:567-572.
5. van Bijsterveld O. Diagnosis and differential diagnosis of keratoconjunctivitis sicca associated with tear gland degeneration. Clin Exp Rheumatol 1990, 8:S3-S6.
6. Norn M. Vital staining of the cornea and conjunctiva. Am J Ophthalmol 1967, 64:1078-1080.
7. Machado L.M., Castro R.S., Fontes B.M. Staining patterns in dry eye syndrome: rose bengal versus lissamine green. Cornea 2009, 28:732.
8. van Bijsterveld O. Diagnostic test in the sicca syndrome. Arch Ophthalmol 1969, 82:10-14.
9. Whitcher J., Shiboski C., Shiboski S., Heidenreich A., Kitagawa K., Zhang S., et al. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren's syndrome international registry. Am J Ophthalmol 2010, 149:405-415.
10. Mengher L., Pander K., Bron A. Non-invasive tear film break-up time: sensitivity and specificity. Acta Ophthalmol 1986, 64:441-444.
11. Kalk W., Mansour K., Vissink A., Spijkervet F., Bootsma H., Kalenberg C., et al. Oral and ocular manifestations in Sjögren's syndrome. J Rheumatol 2002, 29:924-930.
12. Jones L. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966, 51:58-66.
13. Jones L. The lacrimal secretory system and its treatment. Am J Ophthalmol 1966, 62:47-60.
14. De Monchy I., Gendron G., Miceli C., Pogorzalek N., Mariette X., Labetoulle M. Combination of the Schirmer I and phenol red thread tests as a rescue strategy for diagnosis of ocular dryness associates with Sjögren's syndrome. Invest Ophthalmol Vis Sci 2011, 52:5167-5173.
15. Xu K.P., Yagi Y., Toda I. Tear function index. Arch Ophthalmol 1995, 113:84-88.
16. Vitali C., Moutsopoulos H., Bombardieri S., The European Community Study Group on Diagnostic Criteria for Sjögren's syndrome Sensitivity and specificity of tests for ocular and oral involvement in Sjögren's syndrome. Ann Rheum Dis 1994, 53:637-647.
17. Da Dait S., Moncada A., Priori R., Valesini G., Pivetti-Pezzi P. The lactoferrin tear test in the diagnosis of Sjögren's syndrome. Eur J Ophthalmol 1996, 6:284-285.
18. Goren M., Goren S. Diagnostic test in patients with symptoms of keratoconjunctivitis sicca. Am J Ophthalmol 1988, 106:570-574.
19. Lucca J., Nuñez J., Farris F. A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, and tear osmolarity. Contact Lens Assoc Ophthamol J 1990, 16:109-112.
20. Utine C.A., Biçakçigil M., Yavuz S., Çiftçi F. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome. Curr Eye Res 2011, 36:683-690.
21. Tomlinson A., Khanal S., Ramaesh K., Diaper D., McFadyen A. Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci 2006, 47:4309-4315.
22. Roland M., Refojo M., Kenyon K. Increased tear evaporation in eyes with keratoconjunctivitis sicca. Arch Ophthalmol 1983, 101:557-558.
23. Mainstone J.C., Bruce A.S., Golding T.R. Tear meniscus measurement in the diagnosis of dry eye. Curr Eye Res 1996, 15:653-661.
24. Versura P., Frigato M., Cellini M., Mule R., Malavolta N., Campos E. Diagnostic performance of tear function tests in Sjögren's syndrome patients. Eye 2007, 21:229-237.
25. Aguilar A., Fonseca L., Craxatto O. Sjögren's syndrome: a comparative study of impression cytology of the conjunctiva and bucal mucosa, and salivary gland biopsy. Cornea 1991, 10:203-206.
26. Maragou M., Vaikousis E., Ntre A., Koronis N., Georgiou P., Hatzidimitriou E., et al. Tear and saliva ferning test in Sjögren's syndrome. Clin Rheumatol 1996, 15:125-132.
27. Vaikoussis E., Georgiou P., Nomicarios D. Tear mucus ferning in patients with Sjögren's syndrome. Doc Ophthamol 1994, 87:145-151.
28. Vitali C., Bombardiere S., Jonsson R., Moutsopoulos H., Alexander E., Carsons S., et al. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European consensus group. Ann Rheum Dis 2002, 61:554-558.
29. Shiboski S., Shiboski C., Criswell A., Baer A., Challacombe S., Lanfranchi H., et al. American college of Rheumatology classification criteria for Sjögren's syndrome: a data-driven expert consensus approach in the Sjögren's international collaborative clinical alliance cohort. Arthritis Care Res 2012, 4:475-487.
30. Seror R., Ravaud P., Bowman S., Baron G., Tzioufas A., Theander E., et al. EULAR Sjögren's syndrome disease activity index (ESSDAI): development of a consensus systemic disease activity index for primary Sjögren's syndrome. Ann Rheum Dis 2009, 69:1103-1109.
31. Kalk W., Vissink A., Stegenga B., Bootsma H., Nieuw A., Kallenber C. Sialometry and sialochemestry: a non-invasive approach for diagnosing Sjögren's syndrome. Ann Rheum Dis 2002, 61:137-144.
32. Kalk W., Vissink A., Spijkervet F., Bootsma H., Kallenberg C., Nieuw A. Sialometry and sialochemestry: diagnostic tools for Sjögren's syndrome. Ann Rheum Dis 2001, 60:1110-1116.
33. Al-Hashimi I., Haghighat N., Fox P. Salivary electrophoresis in the diagnosis of Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endodon 1998, 85:542-547.
34. el-Miedany Y., el-Hady S., el-Baddin M. Validity of the saliva ferning test for the diagnosis of dry mouth in Sjögren's syndrome. Rev Rheum Engl Ed 1999, 66:73-78.
35. Inamura T., Ino C., Katoh M., Kishimoto A., Kumazawa H., Matsumoto A., et al. A simple method to estimate the secretion of saliva from minor salivary glands using iodine-starch reaction. Laryngoscope 2001, 111:272-277.
36. Dawes C. Physiological factors affecting salivary flow rate, oral sugar clearance and the sensation of dry mouth in men. J Dent Res 1987, 66:648-653.
37. Sánchez-Guerrero J., Aguirre-Garcia E., Pérez-Dosal M., Kraus A., Cardiel M., Soto-Rojas A. The wafer test: a semi-quantitative test to screen for xerostomia. Rheumatology 2002, 41:381-389.
38. Kohler P., Winter M. A quantitative test for xerostomia. The Saxon test, an oral equivalent of the Schirmer test. Arthritis Rheum 1985, 28:1128-1132.
39. López-Jornet P., Camacho-Alonso F., Bermejo-Fenoll A. A simple test for salivary gland hypofunction using oral Schirmer's test. J Oral Pathol Med 2006, 35:244-248.
40. Sreebny L., Valdini A. Xerostomia part I: relationship to other oral symptoms and salivary gland hypofunction. Oral Surg Oral Med Oral Pathol Oral Radiol Endodon 1988, 66:451-458.
41. Márton K., Boros I., Varga G., Zelles T., Fejérdy P., Zeher M., et al. Evaluation of palatal saliva flow rate and oral manifestations in patients with Sjögren's syndrome. Oral Dis 2006, 12:480-486.
42. Skopouli F.N., Siouna-Fatourou H.I., Ziciadis C., Moutsopoulos H.M. Evaluation of unstimulated whole saliva flow rate and stimulated parotid flow as confirmatory test for xerostomia. Clin Exp Rheumatol 1989, 7:127-129.
43. Kanehira T., Yamaguchi T., Asano K., Morita M., Maeshima E., Matsuda A., et al. A screening test for capsaicin-stimulated salivary flow using filter paper: a study for diagnosis of hyposalivation with a complaint of dry mouth. Oral Surg Oral Med Oral Pathol Oral Radiol Endodon 2011, 112:73-80.
44. Speight P., Kaul A., Melson R. Measurement of whole unstimulated saliva flow in the diagnosis of Sjögren's syndrome. Ann Rheum Dis 1992, 51:499-502.
45. Pennec Y., Letoux G., Leroy J., Youinou P. Reappraisal of test for xerostomia. Clin Exp Rheumatol 1993, 11:523-528.
46. Bookman A., Shen H., Cook R., Bailey D., McComb R., Rutka J., et al. Whole stimulated salivary flow: correlation with the pathology of inflammation and damage in minor salivary gland biopsy specimens form patients with primary Sjögren's syndrome but not patients with sicca. Arthritis Rheum 2011, 63:2014-2020.
47. Shiffman R., Christanson M., Jacobsen G. Reliability and validity of the ocular surface disease index. Arch Ophthamol 2000, 118:615-621.
48. Begley C., Caffery B., Chalmers R., Mitchell G., the Dry Eye Investigation (DREI) Study Group Use of the dry eye questionnaire to measure symptoms of ocular irritation in patients with aqueous tear deficit dry eye. Cornea 2002, 21(7):664-670.
49. Thomson W.M., Chalmers J.M., Spencer A.J., Williams S.M. The xerostomia inventory: a multi-item approach to measuring dry mouth. Community Dent Health 1999, 16:12-17.
50. Bowman S., Booth D., Platts R., Field A., Rostron J., UK Sjögren's Interest Group Validation of the sicca symptoms inventory for clinical studies of Sjögren's syndrome. J Rheumatol 2003, 30:1259-1266.
51. Bowman S., Booth D., Platts R., UK Sjögren's Interest Group Measurements of fatigue and discomfort in primary Sjögren's syndrome using a new questionnaire tool. Rheumatology 2004, 43:758-764.
52. Holly F. Dry eye and the Sjögren's syndrome. Scand J Rheumatol 1986, (Suppl. 61):201-205.
53. Mackie I., Seal D. Confirmatory tests for the dry eye of Sjögren's syndrome. Scand J Rheumatol 1986, (Suppl. 61):220-223.
54. Seror R., Ravaud P., Mariette X., Bootsma H., Theander E., Hansen A., et al. EULAR Sjögren's syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sjögren's syndrome. Ann Rheum Dis 2011, 70:968-972.
55. Bowman S., Sutcliffe N., Isenberg D., Goldblatt F., Adler M., Price E., et al. Sjögren's syndrome clinical activity index (SCAI) a systemic disease activity measure for use in clinical trials in primary Sjögren's syndrome. Rheumatology 2007, 46:1845-1851.
56. Ware J., Snow K., Kosinki M., Gandek B. SF-36 health survey. Manual and interpretation guide 1993, The Health Institute, New England Medical Centre, Boston, MA.
57. Cella D., Yount S., Sorensen M., Chartash E., Sengupta N., Grober J. Validation of the functional assessment of chronic illness therapy fatigue scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol 2005, 32:811-819.
58. Chalder T., Berelowitz G., Pawlikowska T., Watts L., Wessely S., Wright D., et al. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153.
59. Smets E., Garssen B., Bonke B., De Haes J. The multidimensional fatigue inventory psychometric qualities of an instrument to assess fatigue. J Psychosom Res 1995, 39:315-325.
60. Krupp L., LaRocca N., Muir-Nash J., Steinberg A. The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 1989, 46:112-113.
61. Fisk J., Ritvo P., Ross L., Haase D., Marrie T., Sclhech W. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 1994, 18(Suppl. 1):S79-S83.
62. Berendregt P., Visser M., Smets E., Tulen J., van den Meiracker A., Boosma F., et al. Fatigue in primary Sjögren's syndrome. Ann Rheum Dis 1998, 57:291-295.
63. Lwin C., Bishay M., Platts R., Booth D., Bowman S. The assessment of fatigue in primary Sjögren's syndrome. Scand J Rheumatol 2003, 32:33-37.
64. Bowman S., Hamburger J., Richards A., Barry R., Rauz S. Patient-reported outcomes in primary Sjögren's syndrome: comparison of the long and short versions of the profile of fatigue and discomfort-sicca symptoms inventory. Rheumatology 2009, 48:140-143.
65. Sutcliffe N., Stoll T., Pyke S., Isenberg D. Functional disability and end organ damage in patients with SLE, SLE and Sjögren's syndrome and primary SS. J Rheumatol 1998, 25:63-68.
66. Group EuroQol EuroQoL a new facility for the measurement of health related quality of life. Health Policy 1999, 16. 199-208.
67. Slade G., Spencer A. Development and evaluation of the oral health impact profile. Community Dent Health 1994, 11:3-11.
68. Schiffman R., Christianson M., Jacobsen G., Hirsch J., Reis B. Reliability and validity of the ocular surface disease index. Arch Ophthamol 2000, 118:615-621.
69. Abetz L., Rajagopalan K., Mertzanis P., Begley C., Barnes R., Chalmers R., et al. Impact of dye eye on everyday life (IDEEL) study group. Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcome (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Outcomes 2011, 9:111.
70. Rajagopalan K., Abetz L., Mertzanis P., Espindle D., Begley C., Chalmers R., et al. Comparing the discriminative validity of two generic and one disease-specific health-related quality of life measures in a sample of patients with dry eyes. Value Health 2005, 8:168-174.
71. Campar A., Isenberg D. Primary Sjögren's syndrome activity and damage indices comparison. Eur J Clin Invest 2010, 40:636-644.
72. Asmussen K., Andersen V., Bendien G., Bendtzen K., Prause J., Thorn J., et al. Quantitative assessment of clinical disease status in primary Sjögren's syndrome. Scand J Rheumatol 1997, 26:197-205.
73. Vitali C., Bencivelli W., Isenberg D., Smolen J., Snaith M., Sciuto M., et al. Disease activity in systemic lupus erythematosus: report of the consensus study group of the European workshop for rheumatology research. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992, 10:541-547.
74. Hay E., Bacon P., Gordon C., Isenberg D., Madison P., Snaith J., et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med 1993, 86(7):447-458.
75. Seror R., Marriette X., Bowman S., Baron G., Gottenberg J., Boostma H., et al. Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European league against rheumatism Sjögren's syndrome disease activity index. Arthritis Care Res 2010, 62:551-558.
76. Meiners P., Arends S., Brouwer E., Spikervet F., Vissink A., Bootsma H. Responsiveness of disease activity indices ESSPRI and ESSDAI in patients with primary Sjögren's syndrome treated with rituximab. Ann Rheum Dis 2012, 71:1297-1302.
77. Barry R., Sutcliffe N., Isenberg D., Price E., Goldblatt F., Adler M., et al. The Sjögren's syndrome damage index- a damage index for use in clinical trials and observational studies in primary Sjögren's syndrome. Rheumatology 2008, 47:1193-1198.
78. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., et al. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. J Rheumatol 1992, 19:1820-1821.